Indication

Viral hepatitis A prevention

Viral hepatitis A prevention refers to pre-exposure prophylaxis or post-exposure immunization against infection caused by the hepatitis A virus (HAV), an enterically transmitted picornavirus that targets the hepatic system. Read more about Viral hepatitis A prevention

4 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Viral hepatitis A prevention therapies.

Showing 1–4 of 4 drugs

Filter & compare in the drug finder →Opens the drug finder with Viral hepatitis A prevention preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Viral hepatitis A prevention.

Viral hepatitis A prevention refers to pre-exposure prophylaxis or post-exposure immunization against infection caused by the hepatitis A virus (HAV), an enterically transmitted picornavirus that targets the hepatic system.

Transmission primarily occurs via the fecal-oral route through direct contact with an infectious person or ingestion of contaminated food or water, placing non-immune children, travelers to endemic areas, and populations experiencing homelessness or substance use at heightened risk.

Pathophysiologically, HAV replication in hepatocytes triggers immune-mediated hepatocellular injury, clinically manifesting as an acute, self-limited illness characterized by fever, malaise, nausea, right upper quadrant abdominal pain, dark urine, and jaundice.

Prophylaxis aims to avert symptomatic acute hepatitis, prolonged cholestasis, and rare complications such as fulminant hepatic failure in susceptible individuals.

Personalize your experience

Follow Viral hepatitis A prevention and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it